Conversation galante: How the immune and the neuroendocrine systems talk to each other

Autoimmunity Reviews

Volumn 7, Issue 1, 2007, Pages 23-29

  Di Comite, Gabriele ^a   Grazia Sabbadini, Maria ^a   Corti, Angelo ^a   Rovere Querini, Patrizia ^a   Manfredi, Angelo A ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Apoptotic cell clearance; Glucocorticoids; Neuroendocrine system; Pro inflammatory cytokines

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ACETYLCHOLINE; AUTOANTIGEN; CELL ENZYME; GLUCOCORTICOID; NEUROPEPTIDE; NORADRENALIN;

APOPTOSIS; AUTOIMMUNITY; AUTONOMIC NERVE; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME REGULATION; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; LYMPHOID ORGAN; MACROPHAGE; NEUROENDOCRINE SYSTEM; NEUROSECRETORY CELL; PERIPHERAL NERVOUS SYSTEM; PHAGOCYTE; REVIEW; SIGNAL TRANSDUCTION; TISSUE INJURY;

ANIMALS; CENTRAL NERVOUS SYSTEM; CYTOKINES; GLUCOCORTICOIDS; HORMONES; HUMANS; IMMUNE SYSTEM; INFLAMMATION; NEUROPEPTIDES; NEUROSECRETORY SYSTEMS;

EID: 35448956094     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2007.03.004     Document Type: Review

References (40)

1. Toni R. The neuroendocrine system: organization and homeostatic role. J Endocrinol Invest 27 6 Suppl (2004) 35-47
2. Sternberg E.M. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol 6 4 (2006) 318-328
3. Webster J.I., Tonelli L., and Sternberg E.M. Neuroendocrine regulation of immunity. Annu Rev Immunol 20 (2002) 125-163
4. Baumann I., Kolowos W., Voll R.E., et al. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum 46 1 (2002) 191-201
5. Bondanza A., Zimmermann V.S., Dell'Antonio G., et al. Requirement of dying cells and environmental adjuvants for the induction of autoimmunity. Arthritis Rheum 50 5 (2004) 1549-1560
6. Bouman A., Heineman M.J., and Faas M.M. Sex hormones and the immune response in humans. Hum Reprod Updat 11 4 (2005) 411-423
7. Cutolo M., Sulli A., Pizzorni C., et al. Circadian rhythms: glucocorticoids and arthritis. Ann NY Acad Sci 1069 (2006) 289-299
8. Elenkov I.J. Glucocorticoids and the Th1/Th2 balance. Ann NY Acad Sci 1024 (2004) 138-146
9. Matyszak M.K., Citterio S., Rescigno M., et al. Differential effects of corticosteroids during different stages of dendritic cell maturation. Eur J Immunol 30 4 (2000) 1233-1242
10. Dumitriu I.E., Baruah P., Manfredi A.A., et al. HMGB1: guiding immunity from within. Trends Immunol 26 7 (2005) 381-387
11. Pitzalis C., Pipitone N., and Perretti M. Regulation of leukocyte-endothelial interactions by glucocorticoids. Ann NY Acad Sci 966 (2002) 108-118
12. Rocha-Viegas L., Vicent G.P., Baranao J.L., et al. Glucocorticoids repress Bcl-X expression in lymphoid cells by recruiting STAT5B to the P4 promoter. J Biol Chem (2006)
13. Madsen-Bouterse S.A., Rosa G.J., and Burton J.L. Glucocorticoid modulation of Bcl-2 family members A1 and Bak during delayed spontaneous apoptosis of bovine blood neutrophils. Endocrinology 147 8 (2006) 3826-3834
14. Rovere-Querini P., Antonacci S., Dell'Antonio G., et al. Plasma and tissue expression of the long pentraxin 3 during normal pregnancy and preeclampsia. Obstet Gynecol 108 1 (2006) 148-155
15. Doria A., Iaccarino L., Sarzi-Puttini P., et al. Estrogens in pregnancy and systemic lupus erythematosus. Ann NY Acad Sci 1069 (2006) 247-256
16. Sargent I.L., Borzychowski A.M., and Redman C.W. NK cells and human pregnancy - an inflammatory view. Trends Immunol 27 9 (2006) 399-404
17. Metz-Boutigue M.H., Kieffer A.E., Goumon Y., et al. Innate immunity: involvement of new neuropeptides. Trends Microbiol 11 12 (2003) 585-592
18. Harle P., Mobius D., Carr D.J., et al. An opposing time-dependent immune-modulating effect of the sympathetic nervous system conferred by altering the cytokine profile in the local lymph nodes and spleen of mice with type II collagen-induced arthritis. Arthritis Rheum 52 4 (2005) 1305-1313
19. del Rey A., Roggero E., Kabiersch A., et al. The role of noradrenergic nerves in the development of the lymphoproliferative disease in Fas-deficient, lpr/lpr mice. J Immunol 176 11 (2006) 7079-7086
20. de Jonge W.J., van der Zanden E.P., et al., The FO. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 6 8 (2005) 844-851
21. Huston J.M., Ochani M., Rosas-Ballina M., et al. Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med 203 7 (2006) 1623-1628
22. Guhl S., Lee H.H., Babina M., et al. Evidence for a restricted rather than generalized stimulatory response of skin-derived human mast cells to substance P. J Neuroimmunol 163 1-2 (2005) 92-101
23. Delgado M., Pozo D., and Ganea D. The significance of vasoactive intestinal peptide in immunomodulation. Pharmacol Rev 56 2 (2004) 249-290
24. Wheway J., Mackay C.R., Newton R.A., et al. A fundamental bimodal role for neuropeptide Y1 receptor in the immune system. J Exp Med 202 11 (2005) 1527-1538
25. Prod'homme T., Weber M.S., Steinman L., et al. A neuropeptide in immune-mediated inflammation, Y?. Trends Immunol 27 4 (2006) 164-167
26. Ferrero E., Magni E., Curnis F., et al. Regulation of endothelial cell shape and barrier function by chromogranin A. Ann NY Acad Sci 971 (2002) 355-358
27. Ferrero E., Scabini S., Magni E., et al. Chromogranin A protects vessels against tumor necrosis factor alpha-induced vascular leakage. FASEB J 18 3 (2004) 554-556
28. Blois A., Srebro B., Mandala M., et al. The chromogranin A peptide vasostatin-I inhibits gap formation and signal transduction mediated by inflammatory agents in cultured bovine pulmonary and coronary arterial endothelial cells. Regul Pept 135 1-2 (2006) 78-84
29. di Comite G., Marinosci A., Di Matteo P., et al. Neuroendocrine modulation induced by selective blockade of TNF-alpha in rheumatoid arthritis. Ann NY Acad Sci 1069 (2006) 428-437
30. Saeed R.W., Varma S., Peng-Nemeroff T., et al. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med 201 7 (2005) 1113-1123
31. De Rosa M.J., Esandi Mdel C., Garelli A., et al. Relationship between alpha 7 nAChR and apoptosis in human lymphocytes. J Neuroimmunol 160 1-2 (2005) 154-161
32. Wang H., Liao H., Ochani M., et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 10 11 (2004) 1216-1221
33. Dumitriu I.E., Baruah P., Valentinis B., et al. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol 174 12 (2005) 7506-7515
34. Gilmour J.S., Coutinho A.E., Cailhier J.F., et al. Local amplification of glucocorticoids by 11β-hydroxysteroid dehydrogenase type 1 promotes macrophage phagocytosis of apoptotic leukocytes. J Immunol 176 12 (2006) 7605-7611
35. Hochberg Z., Friedberg M., Yaniv L., et al. Hypothalamic regulation of adiposity: the role of 11β-hydroxysteroid dehydrogenase type 1. Horm Metab Res 36 6 (2004) 365-369
36. Freeman L., Hewison M., Hughes S.V., et al. Expression of 11β-hydroxysteroid dehydrogenase type 1 permits regulation of glucocorticoid bioavailability by human dendritic cells. Blood 106 6 (2005) 2042-2049
37. Sternberg E.M. Neuroendocrine regulation of autoimmune/inflammatory disease. J Endocrinol 169 3 (2001) 429-435
38. Engstrom L., Mackerlova L., and Blomqvist A. Lipopolysaccharide induces preproenkephalin transcription in hypophysiotropic neurons of the rat paraventricular hypothalamic nucleus suggesting a neuroendocrine role for enkephalins during immune stress. Neuroscience 142 3 (2006) 781-788
39. Straub R.H., Harle P., Sarzi-Puttini P., et al. Tumor necrosis factor-neutralizing therapies improve altered hormone axes: an alternative mode of antiinflammatory action. Arthritis Rheum 54 7 (2006) 2039-2046
40. Straub R.H., Harle P., Yamana S., et al. Anti-interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled study. Arthritis Rheum 54 6 (2006) 1778-1785